nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

01.07.2012

Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature

verfasst von: Shuchi Gulati, Anthony A. Donato

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

A 2010 US report recently detected the presence of levamisole in greater than 77 % of seized cocaine samples. A syndrome of retiform purpura, often involving ears and flanks, with vasculopathy or vasculitis on biopsy, associated with anti-nuclear cytoplasmic antibodies as well as antiphospholipid antibodies, previously associated with therapeutic use of levamisole has now re-emerged, and is associated with cocaine adulterated with levamisole. Patients with this unusual constellation of signs and laboratory findings should be questioned about exposure to cocaine.

Chang A, Osterloh J, Thomas J (2010) Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 88(3):408–411PubMedCrossRef

Fucci N (2007) Unusual adulterants in cocaine seized on Italian clandestine market. Forensic Sci Int 172(2–3):e1PubMedCrossRef

Anon. EMCDDA | 2010 Annual report on the state of the drugs problem in Europe. http://www.emcdda.europa.eu/publications/annual-report/2010. Accessed 30 Sept, 2011

Brunt TM, Rigter S, Hoek J et al (2009) An analysis of cocaine powder in the Netherlands: content and health hazards due to adulterants. Addiction 104(5):798–805PubMedCrossRef

Zhu NY, Legatt DF, Turner AR (2009) Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 150(4):287–289PubMed

Anon. 44849p.pdf. http://www.justice.gov/ndic/pubs44/44849/44849p.pdf. Accessed 30 Sept, 2011

Raymon LP, Isenschmid DS (2009) Letter to the editor: the possible role of levamisole in illicit cocaine preparations. J Anal Toxicol 33(9):620–622PubMed

Ho ENM, Leung DKK, Leung GNW et al (2009) Aminorex and rexamino as metabolites of levamisole in the horse. Anal Chim Acta 638(1):58–68PubMedCrossRef

Bertol E, Mari F, Milia MGD et al (2011) Determination of aminorex in human urine samples by GC-MS after use of levamisole. J Pharm Biomed Anal 55(5):1186–1189PubMedCrossRef

10.

Macfarlane DG, Bacon PA (1978) Levamisole-induced vasculitis due to circulating immune complexes. Br Med J 1(6110):407–408PubMedCrossRef

11.

Scheinberg MA, Bezerra JB, Almeida FA, Silveira LA (1978) Cutaneous necrotising vasculitis induced by levamisole. Br Med J 1(6110):408PubMedCrossRef

12.

Laux-End R, Inaebnit D, Gerber HA, Bianchetti MG (1996) Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 75(4):355–356PubMedCrossRef

13.

Rongioletti F, Ghio L, Ginevri F et al (1999) Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 140(5):948–951PubMedCrossRef

14.

Menni S, Pistritto G, Gianotti R, Ghio L, Edefonti A (1997) Ear lobe bilateral necrosis by levamisole induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 14(6):477–479PubMedCrossRef

15.

Buchanan JA, Vogel JA, Eberhardt AM (2011) Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 7(1):83–84PubMedCrossRef

16.

Lee BL, Stone JH, Gimbel D, Khosroshahi A (2010) A 44-year-old woman with cutaneous bullae and extensive skin necrosis. Arthritis Care Res 62(12):1805–1811CrossRef

17.

Walsh NMG, Green PJ, Burlingame RW, Pasternak S, Hanly JG (2010) Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 37(12):1212–1219PubMedCrossRef

18.

Dy I, Pokuri V, Olichney J, Wiernik P. Levamisole-adulterated in cocaine causing agranulocytosis, vasculopathy, and acquired protein S deficiency. Annals of Hematology. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21773730. Accessed 30 Sept, 2011

19.

Bhinder SK, Majithia V (2007) Cocaine use and its rheumatic manifestations: a case report and discussion. Clin Rheumatol 26(7):1192–1194PubMedCrossRef

20.

Farhat EK, Muirhead TT, Chaffins ML, Douglass MC (2010) Levamisole-induced cutaneous necrosis mimicking coagulopathy. Arch Dermatol 146(11):1320–1321PubMedCrossRef

21.

Waller JM, Feramisco JD, Alberta-Wszolek L, McCalmont TH, Fox LP (2010) Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit? J Am Acad Dermatol 63(3):530–535PubMedCrossRef

22.

Jenkins J, Babu K, Hsu-Hung E, Robinson-Bostom L, Kroumpouzos G (2011) ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisole-adulterated cocaine: a distinctive clinicopathologic presentation. J Am Acad Dermatol 65(1):e14–e16PubMedCrossRef

23.

Ullrich K, Koval R, Koval E, Bapoje S, Hirsh JM (2011) Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol 17(4):193–196PubMed

24.

Zwang NA, Van Wagner LB, Rose S (2011) A case of levamisole-induced systemic vasculitis and cocaine-induced midline destructive lesion: a case report. J Clin Rheumatol 17(4):197–200PubMed

25.

Han C, Sreenivasan G, Dutz JP (2011) Reversible retiform purpura: a sign of cocaine use. Can Med Assoc J 183(9):E597–E600CrossRef

26.

Gross RL, Brucker J, Bahce-Altuntas A et al (2011) A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol 30(10):1385–1392PubMedCrossRef

27.

Geller L, Whang TB, Mercer SE, Phelps R (2011) Retiform purpura: a new stigmata of illicit drug use? Dermatol Online J 17(2):7PubMed

28.

Van Wieren A, Kapoor M, Rao P, Gardner R (2010) A new low for an old high: neutropenia induced by levamisole-adulterated cocaine. Med Health R I 93(10):320–321PubMed

29.

Click J (2011) Levamisole-induced retiform purpura. J Drugs Dermatol 10(2):217PubMed

30.

Poon SH, Baliog CR Jr, Sams RN, et al. Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia. Seminars in Arthritis and Rheumatism. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21868067. Accessed 30 Sept, 2011

31.

Friedman DR, Wolfsthal SD (2005) Cocaine-induced pseudovasculitis. Mayo Clin Proc 80(5):671–673PubMedCrossRef

32.

Bradford M, Rosenberg B, Moreno J, Dumyati G (2010) Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 152(11):758–759PubMed

33.

de la Hera I, Sanz V, Cullen D, et al. Necrosis of ears after use of cocaine probably adulterated with levamisole. Dermatology (Basel, Switzerland). 2011. http://www.ncbi.nlm.nih.gov/pubmed/21846960. Accessed 30 Sept, 2011

34.

Powell J, Grech H, Holder J (2002) A boy with cutaneous necrosis occurring during treatment with levamisole. Clin Exp Dermatol 27(1):32–33PubMedCrossRef

35.

Neynaber S, Mistry-Burchardi N, Rust C et al (2008) PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol 88(6):594–596PubMed

36.

Zamora-Quezada JC, Dinerman H, Stadecker MJ, Kelly JJ (1988) Muscle and skin infarction after freebasing cocaine (crack). Ann Intern Med 108(4):564–566PubMed

37.

Wiens MO, Son WK, Ross C, Hayden M, Carleton B (2010) Cases: cocaine adulterant linked to neutropenia. Can Med Assoc J 182(1):57–59CrossRef

38.

John S, Manda S, Hamrock D. Cocaine-induced thrombotic vasculopathy. Am J Med Sci. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21817879. Accessed 30 Sept, 2011

39.

Chung C, Tumeh PC, Birnbaum R (2011) Characteristic purpura of the ears, vasculitis, and neutropenia-a potential public health epidemic associated with levamisole-adulterated cocaine. J. Am Acad Dermatol 65(4):722–725.e2PubMedCrossRef

40.

Barbano G, Ginevri F, Ghiggeri GM, Gusmano R (1999) Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome. Pediatr Nephrol 13(7):602–603PubMedCrossRef

41.

Fthenakis A, Klein PA (2011) Retiform purpura in a patient with a history of cocaine use. Dermatol Online J 17(4):12PubMed

42.

Hodinka L, Géher P, Merétey K et al (1981) Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol 65(4):460–464PubMedCrossRef

43.

Czuchlewski DR, Brackney M, Ewers C et al (2010) Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 133(3):466–472PubMedCrossRef

44.

Oh SH, Kim DS, Ryu DJ, Lee KH (2009) Extensive cutaneous necrosis associated with low titres of cold agglutinins. Clin Exp Dermatol 34(7):e229–e230PubMedCrossRef

45.

Gulati G, Donato A (2009) Cold hemagglutinin hemolysis and hypercoagulable state due to mycoplasma pneumoniae. ASH Annual Meeting Abstracts 114:5094

46.

Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM (2009) Warfarin-induced skin necrosis. J Am Acad Dermatol 61(2):325–332PubMedCrossRef

47.

Zwang NA, Van Wagner LB, Rose S (2011) A case of levamisole-induced systemic vasculitis and cocaine induced midline destructive lesion: a case report. J Clin Rheumatol 17(4):197–200PubMed

48.

Kouassi E, Caillé G, Léry L, Larivière L, Vézina M (1986) Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 7(1):71–89PubMedCrossRef

Titel: Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature
verfasst von: Shuchi Gulati
Anthony A. Donato
Publikationsdatum: 01.07.2012
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 1/2012
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-012-0711-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Lupus anticoagulant and ANCA associated thrombotic vasculopathy due to cocaine contaminated with levamisole: a case report and review of the literature

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2012

Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin

Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials

Benefits versus risks of pharmacological prophylaxis to prevent symptomatic venous thromboembolism in unselected medical patients revisited. Meta-analysis of the medical literature

Pre PCI hospital antithrombotic therapy for ST elevation myocardial infarction: striving for consensus

Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin